The latest Novartis action to shutdown RNAi research based on:
"... the lingering problems associated with delivering these therapies tied to the small number of relevant targets they could shoot for drove the move."
http://www.fiercebiotech.com/story/breaking-novartis-slams-brakes-rnai-development-efforts/2014-04-14
This contrasts with the EET and potential Phenomica progress in which:
- The delivery problem has been completely resolved;
- The targeting problem looks like it can be feasibly addressed; and
- The complex RNA payload against gene expression can be replaced with a simple payload against phenotype expression.
Compare the multiple billion$ directed to RNAi programmes - where Phylogica's tens of million$ actually has produced a significantly more effective platform.
- Forums
- ASX - By Stock
- PYC
- slamming on the rnai brakes
slamming on the rnai brakes
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PYC (ASX) to my watchlist
|
|||||
Last
12.0¢ |
Change
-0.010(7.69%) |
Mkt cap ! $559.9M |
Open | High | Low | Value | Volume |
13.0¢ | 13.0¢ | 11.5¢ | $308.5K | 2.533M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
7 | 358350 | 11.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
12.0¢ | 371822 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 458166 | 0.120 |
4 | 165789 | 0.115 |
10 | 476802 | 0.110 |
13 | 1260303 | 0.105 |
18 | 2350155 | 0.100 |
Price($) | Vol. | No. |
---|---|---|
0.120 | 50000 | 1 |
0.125 | 422907 | 3 |
0.130 | 515166 | 6 |
0.135 | 104632 | 1 |
0.140 | 721230 | 7 |
Last trade - 16.10pm 03/09/2024 (20 minute delay) ? |
Featured News
PYC (ASX) Chart |